首页> 美国卫生研究院文献>Oncology Letters >Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2 phosphoinositide 3-kinase and matrix metalloproteinase-2
【2h】

Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2 phosphoinositide 3-kinase and matrix metalloproteinase-2

机译:姜黄素通过下调产生促红细胞生成素的肝细胞癌A2磷酸肌醇3激酶和基质金属蛋白酶2抑制血管生成拟态

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glioblastomas (GBMs) are the most common and aggressive malignant primary brain tumors found in humans. In high-grade gliomas, vasculogenic mimicry (VM) is often detected. VM is the formation of de novo vascular networks by highly invasive tumor cells, instead of endothelial cells. An understanding of the mechanisms of VM formation will contribute to the targeted therapy of GBMs. In the present study, the efficacy of curcumin (CCM) on VM formation and its mechanisms were investigated. It was found that CCM inhibits the VM formation, proliferation, migration and invasion of human glioma U251 cells in a dose-dependent manner. Furthermore, CCM downregulated the protein and mRNA expression of erythropoietin-producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase and matrix metalloproteinase-2, indicating that CCM may function through these factors for the inhibition of VM formation. These data provide novel insights into the use of CCM to antagonize VM, and may contribute to the angiogenesis-targeted therapy of malignant glioma.
机译:胶质母细胞瘤(GBM)是人类中最常见,最具侵略性的恶性原发性脑肿瘤。在高级神经胶质瘤中,常常检测到血管生成模拟物(VM)。 VM是由高侵袭性肿瘤细胞而不是内皮细胞形成的新生血管网络。对VM形成机制的理解将有助于GBM的靶向治疗。在本研究中,研究了姜黄素(CCM)对VM形成的作用及其机制。发现CCM以剂量依赖性方式抑制人神经胶质瘤U251细胞的VM形成,增殖,迁移和侵袭。此外,CCM下调了产生促红细胞生成素的肝细胞癌A2,磷酸肌醇3激酶和基质金属蛋白酶2的蛋白质和mRNA表达,表明CCM可能通过这些因子发挥功能来抑制VM的形成。这些数据提供了关于使用CCM拮抗VM的新颖见解,并可能有助于靶向靶向血管生成的恶性神经胶质瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号